PBI19 BUDGET IMPACT ANALYSIS OF IXEKIZUMAB, GUSELKUMAB,...

Value in Health 2020 / 05 Vol. 23

PBI19 BUDGET IMPACT ANALYSIS OF IXEKIZUMAB, GUSELKUMAB, RISANKIZUMAB AND/OR SECUKINUMAB FOR MANAGEMENT OF MODERATE-TO-SEVERE PSORIASIS IN THE KINGDOM OF SAUDI ARABIA

Al Jedai, A., AL-Mudaiheem, H., Aldail, M., Fatani, M., Binamer, Y., Sharma, Y., Mohamed, O., Awad, N., Al-Amaa, T.
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
23
Journal:
Value in Health
DOI:
10.1016/j.jval.2020.04.086
Date:
May, 2020
File:
PDF, 383 KB
2020
Conversion to is in progress
Conversion to is failed